Arrhythmia Research (HRT) Q1 Profit Slips Amid Stronger Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures sink as Amazon, Intel intensify AI spending fears
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
General and administrative: 482.12K
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Financial Fact:
General and administrative: 482.12K
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Arrhythmia Research Technology, Inc. (NYSE: HRT) reported Q1 EPS of $0.01, versus $0.04 reported last year. Revenue for the quarter came in at $6.18 million, versus $5.59 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- OmniAb (OABI) Reports In-Line Q3 EPS
- Cboe Global Markets (CBOE) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
